Suppliers news and information

A heated takeover battle has erupted around generic-drug company Actavis as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities.
FULL STORY »

Cancer researchers are growing increasingly enthusiastic about harnessing the body's own immune system to fight tumors.
FULL STORY »

The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
FULL STORY »

A new study is questioning the benefits of dual-chamber implantable cardioverter-defibrillators.
FULL STORY »

The Indian generic drugmaker Ranbaxy, which already operates under an unprecedented consent decree banning sales of many of its products in the U.S., agreed to plead guilty in federal court and pay $500 million to resolve allegations of shoddy factory inspections and poor quality control.
FULL STORY »

Cancer patients could face high costs for medications under President Barack Obama's healthcare law, industry analysts and advocates warn. Where you live could make a huge difference in what you'll pay.
FULL STORY »

The CMS and Medicare beneficiaries could have saved an estimated $510 million on drugs used to treat end-stage renal disease in 2011 if the reimbursement rate more accurately reflected current usage of these drugs, according to a report from HHS' inspector general's office.
FULL STORY »

Total spending on prescription drugs declined last year as more Americans filled prescriptions for lower-cost generics and some filled fewer prescriptions in general, according to a new study.
FULL STORY »

ICU Medical, the San Clemente, Calif.-based producer of intravenous medical equipment, is weighing a sale that may fetch more than $1 billion, said people familiar with the matter. The shares rose to their highest closing price since first being sold to the public 21 years ago.
FULL STORY »

It's likely to be another seven weeks before the Food and Drug Administration finalizes long-awaited regulations that will require manufacturers to mark medical devices with unique identifiers that are expected to help track products during recalls, save money and improve patient safety.
FULL STORY »